MiR-214 regulates fracture healing through inhibiting Sox4 and its mechanism

Objective: To investigate the expression of micro ribonucleic acid (miR)-214 in the bone tissue and blood of patients with fragility fracture. Methods: The expression of miR-214 was detected via quantitative reverse transcription-polymerase chain reaction. The effect of miR-214 on proliferation and apoptosis of osteoblasts were detected via methyl thiazolyl tetrazolium assay and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling staining. Results: The expression of miR-214 in the bone tissue and blood of patients with fragility fracture significantly declined. miR-214 could promote the proliferation of osteoblasts and inhibited the apoptosis of osteoblasts. miR-214 is involved in fracture healing through inhibiting Sox4 and promoting phosphorylation of PI3K/AKT pathway. The expression of BSP in cells treated with miR-214 mimics was significantly increased to 2.5-fold (p=0.0168), while the expression of BSP in cells treated with miR-214 AMO was significantly decreased, reduced to 0.3 times (p=0.0397). The expression of BMP2 in cells treated with miR-214 mimics was significantly increased to 2.5-fold (p=0.003), while the expression of BMP2 was significantly decreased in cells treated with miR-214 AMO, reduced to 0.3 times (p=0.0002). miR-214 can regulate the expression of Sox2, PI3K and AKT proteins. Conclusion: MiR-214 regulates the proliferation, apoptosis, bone formation of osteoblasts and participate in the fracture healing process by inhibiting the expression of Sox4, which provided new ideas for clinical treatment of fracture healing.

[1]  Meijuan Zhang,et al.  Activation of GPR120 promotes the metastasis of breast cancer through the PI3K/Akt/NF-&kgr;B signaling pathway , 2019, Anti-cancer drugs.

[2]  Sheng-feng Lu,et al.  Electro‐acupuncture attenuates the mice premature ovarian failure via mediating PI3K/AKT/mTOR pathway , 2019, Life sciences.

[3]  Satya N. Das,et al.  Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells , 2018, Cancer Chemotherapy and Pharmacology.

[4]  Yixiao Xing,et al.  An In Vitro Comparative Study of Multisource Derived Human Mesenchymal Stem Cells for Bone Tissue Engineering. , 2018, Stem cells and development.

[5]  Wenjie Zhang,et al.  The Effects of Platelet-Derived Growth Factor-BB on Bone Marrow Stromal Cell-Mediated Vascularized Bone Regeneration , 2018, Stem cells international.

[6]  Xiaohui Xu,et al.  MicroRNA-137 dysregulation predisposes to osteoporotic fracture by impeding ALP activity and expression via suppression of leucine-rich repeat-containing G-protein-coupled receptor 4 expression. , 2018, International journal of molecular medicine.

[7]  T. Sugiyama.  Observational studies investigating hip fracture risk: a fundamental methodological issue? , 2018, Journal of internal medicine.

[8]  R. Baron,et al.  Targeting WNT signaling in the treatment of osteoporosis. , 2018, Current opinion in pharmacology.

[9]  Qifu Li,et al.  Postmenopausal osteoporosis is associated with elevated aldosterone/renin ratio , 2018, Journal of Human Hypertension.

[10]  T. Gomes,et al.  A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride , 2018, BMC Musculoskeletal Disorders.

[11]  I. Kanazawa,et al.  Diabetes Mellitus-induced Bone Fragility , 2018, Internal medicine.

[12]  S. Hider,et al.  Risk of fragility fracture among patients with gout and the effect of urate-lowering therapy , 2018, Canadian Medical Association Journal.

[13]  Yansong Wang,et al.  Comprehensive Effects of Suppression of MicroRNA-383 in Human Bone-Marrow-Derived Mesenchymal Stem Cells on Treating Spinal Cord Injury , 2018, Cellular Physiology and Biochemistry.

[14]  Bo Ryun Kim,et al.  Comparative effectiveness of fragility fracture integrated rehabilitation management for elderly individuals after hip fracture surgery , 2018, Medicine.

[15]  X-J Wang,et al.  MicroRNA-16 suppressed the invasion and migration of osteosarcoma by directly inhibiting RAB23. , 2018, European review for medical and pharmacological sciences.

[16]  Y. Xie,et al.  MiR-299-5p targets cell cycle to promote cell proliferation and progression of osteosarcoma. , 2018, European review for medical and pharmacological sciences.

[17]  Jianru Xiao,et al.  MicroRNA-493 inhibits the proliferation and invasion of osteosarcoma cells through directly targeting specificity protein 1. , 2018, Oncology letters.

[18]  Xingbo Hu,et al.  miR-142-5p in Bone Marrow-Derived Mesenchymal Stem Cells Promotes Osteoporosis Involving Targeting Adhesion Molecule VCAM-1 and Inhibiting Cell Migration , 2018, BioMed research international.

[19]  M. Xiong,et al.  MicroRNA-192-5p suppresses the initiation and progression of osteosarcoma by targeting USP1 , 2018, Oncology letters.

[20]  T. Gross.  [Patient- vs Physician-Reported Implementation of and Compliance to Anti-Osteoporotic Medication One Year after Sustained Fragility Fracture]. , 2018, Praxis.

[21]  D-W Ge,et al.  Functions of microRNAs in osteoporosis. , 2017, European review for medical and pharmacological sciences.

[22]  A. Rubinacci,et al.  Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture , 2016, BioMed research international.

[23]  J. Marc,et al.  P4 medicine and osteoporosis: a systematic review , 2016, Wiener klinische Wochenschrift.

[24]  A. Baierl,et al.  Circulating microRNA Signatures in Patients With Idiopathic and Postmenopausal Osteoporosis and Fragility Fractures. , 2016, The Journal of clinical endocrinology and metabolism.

[25]  A. Frigessi,et al.  Molecular disease map of bone characterizing the postmenopausal osteoporosis phenotype , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  Jacques P. Brown,et al.  Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  S. Reppe,et al.  Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice , 2007, Journal of Cell Science.